Leerink Partnrs Has Pessimistic Outlook of JNJ Q2 Earnings
Johnson & Johnson (NYSE:JNJ – Free Report) – Analysts at Leerink Partnrs decreased their Q2 2025 EPS estimates for Johnson & Johnson in a research note issued on Wednesday, April 16th. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earnings per share of $2.56 for the quarter, down from their prior […]
Johnson & Johnson (NYSE:JNJ – Free Report) – Analysts at Leerink Partnrs decreased their Q2 2025 EPS estimates for Johnson & Johnson in a research note issued on Wednesday, April 16th. Leerink Partnrs analyst D. Risinger now anticipates that the company will post earnings per share of $2.56 for the quarter, down from their prior […]
